Experts Say HFMD Panic Not Justified, But China Cases Yet To Peak
This article was originally published in PharmAsia News
Executive Summary
Although the season has not peaked for the hand-foot-mouth disease that has killed 34 children in China so far, experts say there is no need for panic in Asia. Not all Asian countries typically report HFMD cases, but health authorities believe the amount and severity of cases in Asia has been greater this year. A Chinese expert told a meeting in Singapore the increase in cases in China was not unusual, but said the public vigilance also had been heightened by actions taken after the 2003 SARS scare. (Click here for more
You may also be interested in...
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win
Topline results from two studies in obstructive sleep apnea among obese adults showed efficacy crossing the 50% threshold that physicians have called clinically meaningful.